Could a gentle brain zap tame Hard-to-Treat seizures?

NCT ID NCT06334952

Recruiting now Disease control Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a non-invasive brain stimulation technique called tDCS can reduce seizures in people with drug-resistant epilepsy. About 60 participants will receive either real or sham (fake) stimulation over 10 days. The goal is to see if this approach safely lowers seizure frequency and improves quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG-RESISTANT EPILEPSY EPILEPSY

Contacts and locations

Locations

Département Neurologie Fonctionnelle et Epilepsie, Hôpital neurologique - Hospices Civils de Lyon
RECRUITING

Bron, 69677, France
Explorations neurophysiologiques - Pôle neurosciences, CHU de Toulouse, Hôpital Pierre Paul Riquet
NOT_YET_RECRUITING

Toulouse, 31059, France
Service Epileptologie et Rythmologie Cérébrale, Hôpital La Timone
RECRUITING

Marseille, 13005, France
Service de Neurologie - CHU de Rennes - Hôpital Pontchaillou
NOT_YET_RECRUITING

Rennes, 35033, France
Service de Neurophysiologie Clinique de l'Enfant et de L'Adulte, Pôle de Neurosciences Cliniques
RECRUITING

Bordeaux, 33000, France
Service de Neurophysiologie clinique - GHU Psychiatrie et Neurosciences Sainte-Anne
NOT_YET_RECRUITING

Paris, 75014, France
Service de Neurophysiologie clinique - Hôpital Roger Salengro, CHU Lille
NOT_YET_RECRUITING

Lille, 59037, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.